REQUEST FOR TRADING HALT In accordance with ASX Listing Rule 17.1, Proteomics International Laboratories Ltd (ASXIQ) (the Company) requests a trading halt of its securities pending the release of an announcement regarding an exclusive licence agreement with Sonic Healthcare USA for the use and commercialisation of the Company’s PromarkerD test in the US market. The Company requests the trading halt remain in place until the earlier of such time as it makes an announcement to the market in relation to the exclusive licence agreement and the commencement of trading on Wednesday, 10 May. The Company is not aware of any reason why the request should not be granted, nor of any other relevant information in relation to this request.
PIQ Price at posting:
90.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
IQ) (the
(20min delay)